Molnupiravir

Incepta gets sublicence to produce Molnupiravir for 105 countries
Health

Incepta gets sublicence to produce Molnupiravir for 105 countries

The antiviral pill showed almost 90% efficacy in preventing hospitalisations and deaths in high-risk patients

Photo: Courtesy
Covid-19 in Bangladesh

Beximco Pharma gets license for oral anti-Covid drug

Picture: Courtesy
Health

Molnupiravir reduces hospitilisation, death in Covid patients: Medical experts

Photo: Courtesy
Covid-19 in Bangladesh

DGHS approves use of ‘Molnupiravir’ to treat symptomatic Covid-19

Oral medicine for Covid-19 now available in Bangladesh 
Health

Oral medicine for Covid-19 now available in Bangladesh